Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Hoebertz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|May 6, 2003
Isolated osteoclast culturesAstrid Hoebertz, Timothy R Arnett
Trends in Pharmacological Sciences|June 26, 2003
Regulation of bone resorption and formation by purines and pyrimidinesAstrid Hoebertz, Timothy R Arnett, Geoffrey Burnstock
Journal of Cellular Biochemistry|September 5, 2002
ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodelingAstrid Hoebertz, Siva Mahendran, Geoffrey Burnstock, et al.
Development (Cambridge, England)|October 29, 2004
The AP1 transcription factor Fra2 is required for efficient cartilage developmentFlorian Karreth, Astrid Hoebertz, Harald Scheuch, et al.
Development (Cambridge, England)|December 15, 2016
Correction: Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
Development (Cambridge, England)|August 20, 2003
Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
The EMBO Journal|July 2, 2004
The Fos-related antigen Fra-1 is an activator of bone matrix formationRobert Eferl, Astrid Hoebertz, Arndt F Schilling, et al.
Journal of Cellular Physiology|May 27, 2003
Hypoxia is a major stimulator of osteoclast formation and bone resorptionTimothy R Arnett, Daniel C Gibbons, Jennifer C Utting, et al.
Nature|June 13, 2008
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaAline Bozec, Latifa Bakiri, Astrid Hoebertz, et al.
The Journal of Cell Biology|February 11, 2004
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defectsLukas Kenner, Astrid Hoebertz, F Timo Beil, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|May 6, 2003
Isolated osteoclast culturesAstrid Hoebertz, Timothy R Arnett
Trends in Pharmacological Sciences|June 26, 2003
Regulation of bone resorption and formation by purines and pyrimidinesAstrid Hoebertz, Timothy R Arnett, Geoffrey Burnstock
Journal of Cellular Biochemistry|September 5, 2002
ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodelingAstrid Hoebertz, Siva Mahendran, Geoffrey Burnstock, et al.
Development (Cambridge, England)|October 29, 2004
The AP1 transcription factor Fra2 is required for efficient cartilage developmentFlorian Karreth, Astrid Hoebertz, Harald Scheuch, et al.
Development (Cambridge, England)|December 15, 2016
Correction: Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
Development (Cambridge, England)|August 20, 2003
Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
The EMBO Journal|July 2, 2004
The Fos-related antigen Fra-1 is an activator of bone matrix formationRobert Eferl, Astrid Hoebertz, Arndt F Schilling, et al.
Journal of Cellular Physiology|May 27, 2003
Hypoxia is a major stimulator of osteoclast formation and bone resorptionTimothy R Arnett, Daniel C Gibbons, Jennifer C Utting, et al.
Nature|June 13, 2008
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaAline Bozec, Latifa Bakiri, Astrid Hoebertz, et al.
The Journal of Cell Biology|February 11, 2004
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defectsLukas Kenner, Astrid Hoebertz, F Timo Beil, et al.
Pageof 1